Paroxetine PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified Paroxetine PCD pharma franchise company offering 5 Paroxetine formulations across Tablets. Every batch is manufactured in DCGI-approved, WHO-GMP compliant facilities and supplied to franchise partners on a monopoly basis with full promotional backing.
What is Paroxetine?
Paroxetine is a selective serotonin reuptake inhibitor (SSRI). It blocks the reuptake of serotonin at the presynaptic neuronal membrane, increasing serotonergic neurotransmission in the central nervous system. It is prescribed for major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalised anxiety disorder and post-traumatic stress disorder. Paroxetine is a prescription-only medicine and must be initiated and monitored by a qualified physician. Detailed compound data is available on PubChem.
Paroxetine Range Available for Franchise
Our Paroxetine portfolio comprises 5 formulations available in the following dosage forms: Tablets. Brand names, compositions, packing and net rates are shared on request with partners holding a valid Drug License. Contact us for the current Paroxetine price list and stock position.
Therapeutic Applications of Paroxetine
Paroxetine is used in the management of depression and the anxiety-spectrum disorders, and is also prescribed off-label in some vasomotor and premature ejaculation protocols under specialist supervision. Prescriptions come predominantly from psychiatrists, followed by neuropsychiatrists, consulting physicians and general practitioners handling first-line mental-health cases.
Because paroxetine is a Schedule H prescription drug, stockists and franchise partners must hold a valid Drug Licence and supply only against a registered medical practitioner's prescription.
Why Paroxetine is a High-Potential Molecule for Distributors
Mental-health prescribing in India has grown steadily as awareness rises and psychiatric consultation moves into tier-2 and tier-3 towns. Paroxetine sits in a chronic-therapy category: patients typically remain on treatment for six months or longer, which produces predictable monthly repeat orders rather than one-off sales. It is also an off-patent, well-established SSRI, so margins are healthy and prescriber familiarity is high. For a distributor building a neuropsychiatry portfolio, paroxetine pairs naturally with SSRIs, benzodiazepine alternatives and mood stabilisers to create a complete psychiatric basket that supports a single-doctor call cycle.
Why Choose Cafoli Lifecare for Your Paroxetine Franchise
Cafoli Lifecare works with over 1000+ franchise partners across India. Partners receive monopoly rights for their district or territory, WHO-GMP certified and DCGI-approved products, complete promotional inputs (visual aids, MR bags, samples, prescription pads, gifts), transparent net rates, and dependable dispatch. Our documentation and stock support are built for distributors who want to scale without operational friction.
References
- PubChem — Paroxetine compound record (NIH / NCBI)
- MedlinePlus — Paroxetine drug information (US National Library of Medicine)
- PubMed — clinical literature on Paroxetine
Our formulations of Paroxetine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: